The number of bariatric surgeries performed annually in the U.S. has taken a sharp drop lately, new research shows, coinciding with the rise of GLP-1 therapy.
The growing use of Ozempic and other GLP-1 drugs has had an outsized, sometimes negative, impact on all sorts of industries, particularly those related to food. Another such casualty, research out to… [+7023 chars]